We aimed to compare the significant difference in GMV among the three groups and to analyze the correlation between serum P-tau-181 levels and GMV in T2DM patients, thereby providing a diagnostic biomarker of diabetic brain injury. The gene discussed is MAPT; the disease is type 2 diabetes mellitus.